Stay updated on Intravitreal Retinal Progenitor Cells in Retinitis Pigmentosa Clinical Trial
Sign up to get notified when there's something new on the Intravitreal Retinal Progenitor Cells in Retinitis Pigmentosa Clinical Trial page.

Latest updates to the Intravitreal Retinal Progenitor Cells in Retinitis Pigmentosa Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedA new Locations section is added with California and Massachusetts sites, replacing the previous California Locations and Massachusetts Locations headers; the footer shows Revision: v3.3.3, updating from v3.3.2.SummaryDifference0.3%

- Check15 days agoNo Change Detected
- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedRevision label updated from v3.2.0 to v3.3.2 with no observable changes to study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check37 days agoChange DetectedDeletion of the government funding status notice and related operating information from the ClinicalTrials.gov page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check59 days agoChange DetectedNo meaningful content changes detected; the updates appear to be minor UI/layout adjustments with no changes to study data or eligibility criteria. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check80 days agoChange DetectedUpdate includes a new operating status notice and a version bump to v3.2.0, removing the previous v3.1.0 reference.SummaryDifference3%

- Check88 days agoChange DetectedUpgrade from v3.0.2 to v3.1.0, updating the page version identifier.SummaryDifference0.1%

Stay in the know with updates to Intravitreal Retinal Progenitor Cells in Retinitis Pigmentosa Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Intravitreal Retinal Progenitor Cells in Retinitis Pigmentosa Clinical Trial page.